Skip to Main Content

Paper Details

Plasma P-selectin is an early marker of thromboembolism in COVID-19.
medRxiv
2
2021
COVID, COVID-19, Coagulopathy, D, D-dimer, P-selectin, SARS-CoV, SARS-CoV-2, SARS-CoV-2 infection, VTE, activated endothelial cells, coagulation, endothelial, endothelial cell, hematologic complications, patients, platelet, respiratory distress, thromboembolic events, thromboembolism, venous thromboembolic, venous thromboembolism
Author NameAffiliation
Nir HacohenHarvard Medical School
Nir HacohenMassachusetts General Hospital Cancer Center, Massachusetts General Hospital
Nir HacohenBroad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Nir HacohenHarvard Medical School
Nir HacohenBroad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Nir HacohenMassachusetts General Hospital Cancer Center, Massachusetts General Hospital
Michael R FilbinMassachusetts General Hospital
Michael R FilbinBroad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Michael R FilbinHarvard Medical School
  • 1 - 9

Datasets

Release 1.2